DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

62.46 0.03 (0.05%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $62.46 0.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $62.30
Previous Close $62.43
Daily Range $61.65 - $62.94
52-Week Range $37.38 - $77.80
Market Cap $7.5B
P/E Ratio 480.23
Dividend (Yield) $0.00 (0.0%)
Volume 324,134
Average Daily Volume 1,866,835
Current FY EPS -$0.64




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

A Pro Forma Profit for ISIS Pharmaceuticals, Inc.

But don't get too excited: The biotech is raking in cash from partners, not by selling drugs.

Interesting ISIS Put And Call Options For January 2016

ISIS Pharmaceuticals (ISIS) Weak On High Volume

Benzinga's Top Initiations

Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy

Isis Pharma considers name change after Paris attacks

Alnylam Pharmaceuticals, Inc. Earnings: 100% Positive (Data)

Without any sales, the biotech reiterates its positive pipeline record.

Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

Pipeline Advancement Provides a Double-Digit Percentage Spark for Isis Pharmaceuticals in October

Isis Pharmaceuticals' pipeline juiced shareholder returns in October.

Isis Posts Narrower-than-Expected Loss in Q3, Shares Up

See More ISIS News...

ISIS's Top Competitors

ISIS $62.46 (0.05%)
Current stock: ISIS
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
BIIB $293.21 (0.31%)
Current stock: BIIB